Form 8-K - Current report:
SEC Accession No. 0001104659-21-122546
Filing Date
2021-10-04
Accepted
2021-10-04 16:46:16
Documents
18
Period of Report
2021-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2129080d2_8k.htm   iXBRL 8-K 38069
2 EXHIBIT 4.1 tm2129080d2_ex4-1.htm EX-4.1 108193
3 EXHIBIT 5.1 tm2129080d2_ex5-1.htm EX-5.1 10935
4 EXHIBIT 10.1 tm2129080d2_ex10-1.htm EX-10.1 256696
5 EXHIBIT 99.1 tm2129080d2_ex99-1.htm EX-99.1 17069
9 GRAPHIC tm2129080d2_ex5-1img001.jpg GRAPHIC 5410
10 GRAPHIC tm2129080d2_ex5-1img002.jpg GRAPHIC 6349
  Complete submission text file 0001104659-21-122546.txt   722266

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nrbo-20211001.xsd EX-101.SCH 3204
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrbo-20211001_lab.xml EX-101.LAB 34594
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrbo-20211001_pre.xml EX-101.PRE 22723
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2129080d2_8k_htm.xml XML 3729
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 211303521
SIC: 2834 Pharmaceutical Preparations